Brochure | July 27, 2020

Moving Multiple Sclerosis Trials Forward, Faster

YOUR CRO PARTNER CAN HAVE A SIGNIFICANT IMPACT ON THE SUCCESS OR FAILURE OF YOUR CLINICAL STUDY AND PROGRAM.

As a full-service CRO, Worldwide Clinical Trials has an outstanding track record in starting up and executing MS studies, including beta-interferons, glatiramer acetate monoclonal antibodies, and oral preparations for disease-modifying approaches.

SPECIALIZATION IN MS PROGRAMS FOR ACCELERATED TRIALS

When timing is critical and everyday delays can cost millions, Worldwide’s simple, thorough, streamlined operations are critical to your neurology development program.

Whether your study is a small, focused single-region trial or a study that requires global reach, we designed our specialty MS team – neurologists; experienced clinical monitors and project managers; and regulatory, data management, statistical, scientific, and medical experts – to work collaboratively with you to help you overcome the high-risk, high-cost, time-intensive challenges of MS drug development.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: